Yixue Dong1, Heng Chen1, Yuanyu Zheng1, Ying Guo2, Jung Hye Kwon3, En Liu1, Hong Guo1, Eduardo Bruera4. 1. Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China. 2. Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. 3. Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University, Seoul, Republic of Korea. 4. Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. Electronic address: ebruera@mdanderson.org.
Abstract
CONTEXT: The Edmonton Symptom Assessment System is a simple and widely used questionnaire to assess patient symptoms. OBJECTIVES: We aimed to develop and verify a Chinese version of the Edmonton Symptom Assessment System (C-ESAS) for use with Chinese patients. METHODS: Two hundred ten patients were surveyed in the Department of Gastroenterology of Xinqiao hospital in southwest China. Patients completed the C-ESAS and the Chinese version of the M. D. Anderson Symptom Inventory to assess internal consistency, test-retest reliability, and concurrent validity of the C-ESAS. The questionnaires were completed again two hours later. RESULTS: The C-ESAS demonstrated acceptable internal consistency (Cronbach α = 0.72). This indicated that no question had an inappropriate effect on the score. Pearson correlation coefficients for the C-ESAS symptom scores between baseline and after two hours ranged from 0.47 (95% CI, 0.35-0.89) to 0.92 (95% CI, 0.57-0.94), indicating strong test-retest reliability. The corresponding Chinese version of the M. D. Anderson Symptom Inventory symptom scores ranged from 0.66 (95% CI, 0.58-0.95) to 0.96 (95% CI, 0.73-0.97), indicating good concurrent validity. The average time to complete the C-ESAS differed according to patient education level. CONCLUSION: The C-ESAS is a good tool for measuring multidimensional symptoms in Chinese patients.
CONTEXT: The Edmonton Symptom Assessment System is a simple and widely used questionnaire to assess patient symptoms. OBJECTIVES: We aimed to develop and verify a Chinese version of the Edmonton Symptom Assessment System (C-ESAS) for use with Chinese patients. METHODS: Two hundred ten patients were surveyed in the Department of Gastroenterology of Xinqiao hospital in southwest China. Patients completed the C-ESAS and the Chinese version of the M. D. Anderson Symptom Inventory to assess internal consistency, test-retest reliability, and concurrent validity of the C-ESAS. The questionnaires were completed again two hours later. RESULTS: The C-ESAS demonstrated acceptable internal consistency (Cronbach α = 0.72). This indicated that no question had an inappropriate effect on the score. Pearson correlation coefficients for the C-ESAS symptom scores between baseline and after two hours ranged from 0.47 (95% CI, 0.35-0.89) to 0.92 (95% CI, 0.57-0.94), indicating strong test-retest reliability. The corresponding Chinese version of the M. D. Anderson Symptom Inventory symptom scores ranged from 0.66 (95% CI, 0.58-0.95) to 0.96 (95% CI, 0.73-0.97), indicating good concurrent validity. The average time to complete the C-ESAS differed according to patient education level. CONCLUSION: The C-ESAS is a good tool for measuring multidimensional symptoms in Chinese patients.
Authors: Fliss Em Murtagh; Christina Ramsenthaler; Alice Firth; Esther I Groeneveld; Natasha Lovell; Steffen T Simon; Johannes Denzel; Ping Guo; Florian Bernhardt; Eva Schildmann; Birgitt van Oorschot; Farina Hodiamont; Sabine Streitwieser; Irene J Higginson; Claudia Bausewein Journal: Palliat Med Date: 2019-06-12 Impact factor: 4.762